Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 AcquisitionLawrence Corey, Myron S. Cohen, Pedro Gonzáles et al.|New England Journal of Medicine|2021Cited by 540
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria VaccineDaniel E. Neafsey, Carsten Russ, Dyann F. Wirth et al.|New England Journal of Medicine|2015Cited by 451
Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trialGlenda Gray, Mookho Malahleha, Kathryn Mngadi et al.|The Lancet Infectious Diseases|2024Cited by 40
A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is VaccinatedDean Follmann, Kathleen M. Neuzil, Jonathan Fintzi et al.|Annals of Internal Medicine|2021Cited by 26
Assessing Durability of Vaccine Effect Following Blinded Crossover in COVID-19 Vaccine Efficacy TrialsDean Follmann, Kathleen M. Neuzil, Jonathan Fintzi et al.|medRxiv|2020Cited by 25